These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31010559)

  • 41. Management of Diabetes in the Intrapartum and Postpartum Patient.
    Dude A; Niznik CM; Szmuilowicz ED; Peaceman AM; Yee LM
    Am J Perinatol; 2018 Sep; 35(11):1119-1126. PubMed ID: 29534258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral hypoglycaemic agents in 118 diabetic pregnancies.
    Hellmuth E; Damm P; Mølsted-Pedersen L
    Diabet Med; 2000 Jul; 17(7):507-11. PubMed ID: 10972579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The insulin analog glargine during an unplanned pregnancy.
    Cechurová D; Lacigová S; Jankovec Z; Haladová I; Zourek M; Krcma M; Rusavý Z; Turek J
    Wien Klin Wochenschr; 2006 Oct; 118(19-20):619-20. PubMed ID: 17136338
    [No Abstract]   [Full Text] [Related]  

  • 44. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes.
    Herrera KM; Rosenn BM; Foroutan J; Bimson BE; Al Ibraheemi Z; Moshier EL; Brustman LE
    Am J Obstet Gynecol; 2015 Sep; 213(3):426.e1-7. PubMed ID: 26070699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of oral hypoglycaemic agents in pregnancy.
    Holt RI; Lambert KD
    Diabet Med; 2014 Mar; 31(3):282-91. PubMed ID: 24528229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin analogues in the treatment of diabetes in pregnancy.
    Negrato CA; Montenegro Junior RM; Von Kostrisch LM; Guedes MF; Mattar R; Gomes MB
    Arq Bras Endocrinol Metabol; 2012 Oct; 56(7):405-14. PubMed ID: 23108744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.
    Tieu J; Coat S; Hague W; Middleton P; Shepherd E
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007724. PubMed ID: 29045765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of metformin earlier in pregnancy predicts supplemental insulin therapy in women with gestational diabetes.
    McGrath RT; Glastras SJ; Hocking S; Fulcher GR
    Diabetes Res Clin Pract; 2016 Jun; 116():96-9. PubMed ID: 27321322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin therapy in pregnancy.
    McElduff A; Moses RG
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):161-73. PubMed ID: 22575412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metformin administration during pregnancy - current insight.
    Skibinska M; Zurawska-Klis M; Krekora M; Cypryk K
    Ginekol Pol; 2021; 92(1):46-50. PubMed ID: 33576490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes.
    Garg SK; Frias JP; Anil S; Gottlieb PA; MacKenzie T; Jackson WE
    Endocr Pract; 2003; 9(3):187-93. PubMed ID: 12917059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy of metformin compared with insulin in regulating blood glucose levels during gestational diabetes mellitus: A randomized clinical trial.
    Ghomian N; Vahed SHM; Firouz S; Yaghoubi MA; Mohebbi M; Sahebkar A
    J Cell Physiol; 2019 Apr; 234(4):4695-4701. PubMed ID: 30191995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metformin versus Insulin in the Management of Pre-Gestational Diabetes Mellitus in Pregnancy and Gestational Diabetes Mellitus at the Korle Bu Teaching Hospital: A Randomized Clinical Trial.
    Beyuo T; Obed SA; Adjepong-Yamoah KK; Bugyei KA; Oppong SA; Marfoh K
    PLoS One; 2015; 10(5):e0125712. PubMed ID: 25945500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy.
    Blair RA; Rosenberg EA; Palermo NE
    Curr Diab Rep; 2019 Dec; 19(12):158. PubMed ID: 31811400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Very tight vs. tight control: what should be the criteria for pharmacologic therapy dose adjustment in diabetes in pregnancy? Evidence from randomized controlled trials.
    Caissutti C; Saccone G; Ciardulli A; Berghella V
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):235-247. PubMed ID: 29125636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Managing Diabetes in Pregnancy Before, During, and After COVID-19.
    Murphy HR
    Diabetes Technol Ther; 2020 Jun; 22(6):454-461. PubMed ID: 32396397
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of insulin lispro in pregnancy.
    Calle-Pascual AL; Bagazgoitia J; Calle JR; Charro A; Marañes JP
    Diabetes Nutr Metab; 2000 Jun; 13(3):173-7. PubMed ID: 10963394
    [No Abstract]   [Full Text] [Related]  

  • 58. An Irish National Diabetes in Pregnancy Audit: aiming for best outcomes for women with diabetes.
    Egan AM; Brassill MJ; Brosnan E; Carmody L; Clarke H; Coogan Kelly C; Culliney L; Durkan M; Fenlon M; Ferry P; Hanlon G; Higgins T; Hoashi S; Khamis A; Kinsley B; Kinsley T; Kirwan B; Liew A; McGurk C; McHugh C; Murphy MS; Murphy P; O'Halloran D; O'Mahony L; O'Sullivan E; Nolan M; Peter M; Roberts G; Smyth A; Todd M; Tuthill A; Wan Mahmood WA; Yousif O; P Dunne F;
    Diabet Med; 2020 Dec; 37(12):2044-2049. PubMed ID: 30710451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New technologies for the management of pregestational diabetes mellitus.
    Lee-Parritz A
    Obstet Gynecol Surv; 2012 Mar; 67(3):167-75. PubMed ID: 22901950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes.
    Fuglsang J; Lauszus F; Flyvbjerg A; Ovesen P
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4355-61. PubMed ID: 14557493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.